Concepedia

Phase I Study of JM-216 (an Oral Platinum Analogue) in Combination with Paclitaxel in Patients with Advanced Malignancies

Suzanne Jones, John D. Hainsworth, Howard A. Burris, Dana S. Thompson, Eric Raefsky, Valerie Johnson, Sharon Calvert, C. A. Bulanhagui, David Lebwohl, F. Anthony Greco

Investigational New Drugs · 2002 · 17 citations · 10 references

DOI

Concepts

References

10

Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian Cancer

William P. McGuire, William J. Hoskins, Mark F. Brady et al. · New England Journal of Medicine · 1996 · 2.9K citations · Full text

, , +16

WHO Handbook for Reporting Results of Cancer Treatment

M K Palmer · British Journal of Cancer · 1982 · 2.2K citations · Full text

, , +11

Paclitaxel and carboplatin in combination in the treatment of advanced non-small-cell lung cancer: a phase II toxicity, response, and survival analysis.

Corey J. Langer, John Leighton, Robert L. Comis et al. · Journal of Clinical Oncology · 1995 · 303 citations

, , +17

Phase II trial of paclitaxel, fluorouracil, and cisplatin in patients with advanced carcinoma of the esophagus.

D.H. Ilson, Jaffer A. Ajani, Kapil N. Bhalla et al. · Journal of Clinical Oncology · 1998 · 203 citations

, , +13

Phase I and pharmacokinetic study of an oral platinum complex given daily for 5 days in patients with cancer.

Mark J. McKeage, Florence I. Raynaud, Janet Ward et al. · Journal of Clinical Oncology · 1997 · 93 citations

, , +16